{
    "nctId": "NCT03292198",
    "briefTitle": "Subclinical Lymphedema Treatment Study",
    "officialTitle": "Treatment Indications for Breast Cancer-related Subclinical Lymphedema Identified Through a Bioimpedance Surveillance Model",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer-related Subclinical Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 267,
    "primaryOutcomeMeasure": "L-dex scores",
    "eligibilityCriteria": "Inclusion Criteria:\n\nNew diagnosis of breast cancer, Female, 18 years of age or older, Upcoming unilateral axillary lymph node procedure (biopsy or dissection), Able to provide informed consent\n\nExclusion Criteria:\n\nPre-existing diagnosis of lymphedema, as diagnosed by physician, History of axillary lymph node procedure, including biopsy, dissection, or radiation to, Pregnancy, Pacemaker or other implanted electrical device, Stage 4-5 kidney disease, Severe liver disease, Active infection, Acute Deep Vein Thrombosis, Unmanaged congestive heart failure or a cardiac event in the past 6 months, Prisoners",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}